Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Amgen's stock increased by 2.5% due to positive developments related to its weight loss drug, highlighting its potential in a challenging market. Meanwhile, the Dow Jones experienced a decline of 700 points, reflecting growing concerns about a recession and economic instability.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
